Risedronate Sodium 00093-3098-29
- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2015
- Listing Expires
- December 31, 2027
- Application
- ANDA077132
Need to source Risedronate Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risedronate Sodium Monohydrate | 35 mg/1 |
Drug Class
Bisphosphonate [EPC]Diphosphonates [CS]
Selected Package
00093-3098-29Selected12 BLISTER PACK in 1 CARTON (0093-3098-29) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19)
Other packages for this product(1)
4 BLISTER PACK in 1 CARTON (0093-3098-44) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19)